1887
  1. Home
  2. Eurosurveillance
  3. Volume 29, Issue 50, 12/Dec/2024
  4. Article
Research Open Access
Like 0
Download

Abstract

Background

Within the International Health Regulations framework, the French High Council for Public Health was mandated in 2022 by health authorities to establish a list of priority infectious diseases for public health, surveillance and research in mainland and overseas France.

Aim

Our objective was to establish this list.

Methods

A multi-criteria decision analysis was used, as recommended by the European Centre for Disease Prevention and Control. A list of 95 entities (infectious diseases or groups of these, including the World Health Organization (WHO)-labelled ‘Disease X’) was established by 17 infectious disease experts. Ten criteria were defined to score entities: incidence rate, case fatality rate, potential for emergence and spread, impact on the individual, on society, on socially vulnerable groups, on the healthcare system, and need for new preventive tools, new curative therapies, and surveillance. Each criterion was assigned a relative weight by 77 multidisciplinary experts. For each entity, 98 physicians from various specialties rated each criterion against the entity, using a four-class Likert-type scale; the ratings were converted into numeric values with a nonlinear scale and respectively weighted to calculate the entity score.

Results

Fifteen entities were ranked as high-priorities, including Disease X and 14 known pathologies (e.g. haemorrhagic fevers, various respiratory viral infections, arboviral infections, multidrug-resistant bacterial infections, invasive meningococcal and pneumococcal diseases, prion diseases, rabies, and tuberculosis).

Conclusion

The priority entities agreed with those of the WHO in 2023; almost all were currently covered by the French surveillance and alert system. Repeating this analysis periodically would keep the list updated.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.50.2400074
2024-12-12
2024-12-19
/content/10.2807/1560-7917.ES.2024.29.50.2400074
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/50/eurosurv-29-50-4.html?itemId=/content/10.2807/1560-7917.ES.2024.29.50.2400074&mimeType=html&fmt=ahah

References

  1. Delfraissy JF. La recherche française face aux maladies infectieuses émergentes: de REACTing à l’ANRS- maladies infectieuses émergentes. [French research organization on emerging infectious diseases: From REACTing to ANRS emerging infectious diseases]. Bull Acad Natl Med. 2023;207(3):287-94.  https://doi.org/10.1016/j.banm.2022.11.017  PMID: 36691475 
  2. Nacher M, Epelboin L, Bonifay T, Djossou F, Blaizot R, Couppié P, et al. Migration in French Guiana: Implications in health and infectious diseases. Travel Med Infect Dis. 2024;57:102677.  https://doi.org/10.1016/j.tmaid.2023.102677  PMID: 38049022 
  3. Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, et al. Illegal gold miners in French Guiana: a neglected population with poor health. BMC Public Health. 2017;18(1):23.  https://doi.org/10.1186/s12889-017-4557-4  PMID: 28716015 
  4. Belchior E, Henry S, Badell E, Collet L, Benoit-Cattin T, de Montera AM, et al. Diphtheria in Mayotte, 2007-2015. Emerg Infect Dis. 2017;23(7):1218-20.  https://doi.org/10.3201/eid2307.170262  PMID: 28628446 
  5. World Health Organization (WHO). Biodiversity & Infectious Diseases. Questions & Answers. Geneva: WHO. [Accessed 27 Nov 2024]. Available from: https://www.who.int/docs/default-source/climate-change/qa-infectiousdiseases-who.pdf?sfvrsn=3a624917_3
  6. World Health Organization (WHO). One Health. Geneva: WHO; Oct. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/one-health
  7. Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (Anses). La santé des animaux, c’est aussi la nôtre. [Animal health is also our health]. Maisons-Alfort: Anses; 2023. [Accessed 12 Nov 2024]. Available from: https://www.anses.fr/fr/content/sante-des-animaux-aussi-la-notre
  8. Mehand MS, Millett P, Al-Shorbaji F, Roth C, Kieny MP, Murgue B. World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development. Emerg Infect Dis. 2018;24(9):e171427.  https://doi.org/10.3201/eid2409.171427  PMID: 30124424 
  9. Chambaud L, Hernández-Quevedo C. France. In: Rechel B, Maresso A, Sagan A, Hernández-Quevedo C, Williams G, Richardson E, et al., editors. Organization and financing of public health services in Europe: Country reports Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2018. (Health Policy Series, No. 49.) 3. [Accessed 12 Nov 2024] Available from: https://www.ncbi.nlm.nih.gov/books/NBK507320/?
  10. World Health Organization (WHO). International Health Regulations. Geneva: WHO;2023. [Accessed 12 Nov 2024]. Available from: https://www.who.int/health-topics/international-health-regulations#tab=tab_1
  11. European Centre for Disease prevention and Control (ECDC). ECDC tool for the prioritisation of infectious disease threats. Stockholm: ECDC; 2017. [Accessed 12 Nov 2024]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Tool-for-disease-priority-ranking_handbook-update-dec-18.pdf
  12. Doherty JA. Final report and recommendations from the National Notifiable Diseases Working Group. Can Commun Dis Rep. 2006;32(19):211-25. PMID: 17076030 
  13. Krause G, Working Group on Prioritization at Robert Koch Institute. How can infectious diseases be prioritized in public health? A standardized prioritization scheme for discussion. EMBO Rep. 2008;9(Suppl 1) Suppl 1;S22-7. PMID: 18578019 
  14. Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gärtner B, et al. Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One. 2011;6(10):e25691.  https://doi.org/10.1371/journal.pone.0025691  PMID: 21991334 
  15. Dahl V, Tegnell A, Wallensten A. Communicable diseases prioritized according to their public health relevance, Sweden, 2013. PLoS One. 2015;10(9):e0136353.  https://doi.org/10.1371/journal.pone.0136353  PMID: 26397699 
  16. O’Brien EC, Taft R, Geary K, Ciotti M, Suk JE. Best practices in ranking communicable disease threats: a literature review, 2015. Euro Surveill. 2016;21(17):30212.  https://doi.org/10.2807/1560-7917.ES.2016.21.17.30212  PMID: 27168585 
  17. Klamer S, Van Goethem N, Thomas D, Duysburgh E, Braeye T, Quoilin S, Working group Disease and Criteria selection, Working group Epidemiologists. Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study. BMC Public Health. 2021;21(1):192.  https://doi.org/10.1186/s12889-020-09566-9  PMID: 33482767 
  18. Zhao J, Smith T, Lavigne M, Aenishaenslin C, Cox R, Fazil A, et al. A rapid literature review of multi-criteria decision support methods in the context of one health for all-hazards threat prioritization. Front Public Health. 2022;10:861594.  https://doi.org/10.3389/fpubh.2022.861594  PMID: 35493347 
  19. Collège des universitaires de maladies infectieuses et tropicales. ePilly TROP: Maladies infectieuses et tropicales. 3° édition web; 2022. p 1029. Édition Alinéa Plus, Paris, France. [Accessed 12 Nov 2024]. Available from: https://www.infectiologie.com/UserFiles/File/formation/epilly-trop/livre-epillytrop2022.pdf
  20. World Health Organization (WHO). Prioritizing diseases for research and development in emergency contexts. Geneva: WHO; 2023. [Accessed 12 Nov 2024]. Available from: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
  21. World Health Organization (WHO). The Dubrovnik pledge on surveillance and prioritization of infectious diseases: report on a WHO meeting, Bucharest, Romania. 21-23 November 2002. [Accessed 12 Nov 2024]. Available from: https://iris.who.int/handle/10665/107469
  22. Babai L. Monte-Carlo algorithms in graph isomorphism testing (PDF), Tech. Report, Université de Montréal, Canada. 1979. [Accessed 12 Nov 2024]. Available from: http://people.cs.uchicago.edu/~laci/lasvegas79.pdf
  23. LimeSurvey software (version 6.2.6), Limesurvey GmbH. LimeSurvey: An Open Source survey tool. LimeSurvey GmbH, Hamburg, Germany. [Accessed 12 Nov 2024]. Available from: http://www.limesurvey.org
  24. Cardoen S, Van Huffel X, Berkvens D, Quoilin S, Ducoffre G, Saegerman C, et al. Evidence-based semiquantitative methodology for prioritization of foodborne zoonoses. Foodborne Pathog Dis. 2009;6(9):1083-96.  https://doi.org/10.1089/fpd.2009.0291  PMID: 19715429 
  25. Havelaar AH, van Rosse F, Bucura C, Toetenel MA, Haagsma JA, Kurowicka D, et al. Prioritizing emerging zoonoses in the Netherlands. PLoS One. 2010;5(11):e13965.  https://doi.org/10.1371/journal.pone.0013965  PMID: 21085625 
  26. Humblet MF, Vandeputte S, Albert A, Gosset C, Kirschvink N, Haubruge E, et al. Multidisciplinary and evidence-based method for prioritizing diseases of food-producing animals and zoonoses. Emerg Infect Dis. 2012;18(4):e1.  https://doi.org/10.3201/eid1804.111151  PMID: 22469519 
  27. Cox R, Sanchez J, Revie CW. Multi-criteria decision analysis tools for prioritising emerging or re-emerging infectious diseases associated with climate change in Canada. PLoS One. 2013;8(8):e68338.  https://doi.org/10.1371/journal.pone.0068338  PMID: 23950868 
  28. Brookes VJ, Hernández-Jover M, Cowled B, Holyoake PK, Ward MP. Building a picture: Prioritisation of exotic diseases for the pig industry in Australia using multi-criteria decision analysis. Prev Vet Med. 2014;113(1):103-17.  https://doi.org/10.1016/j.prevetmed.2013.10.014  PMID: 24211032 
  29. Hongoh V, Gosselin P, Michel P, Ravel A, Waaub JP, Campagna C, et al. Criteria for the prioritization of public health interventions for climate-sensitive vector-borne diseases in Quebec. PLoS One. 2017;12(12):e0190049.  https://doi.org/10.1371/journal.pone.0190049  PMID: 29281726 
  30. Otten A, Fazil A, Chemeris A, Breadner P, Ng V. Prioritization of vector-borne diseases in Canada under current climate and projected climate change. Microb Risk Anal. 2020;14:100089.  https://doi.org/10.1016/j.mran.2019.100089 
  31. Cox R, Revie CW, Sanchez J. The use of expert opinion to assess the risk of emergence or re-emergence of infectious diseases in Canada associated with climate change. PLoS One. 2012;7(7):e41590.  https://doi.org/10.1371/journal.pone.0041590  PMID: 22848536 
  32. Economopoulou A, Kinross P, Domanovic D, Coulombier D. Infectious diseases prioritisation for event-based surveillance at the European Union level for the 2012 Olympic and Paralympic Games. Euro Surveill. 2014;19(15):20770.  https://doi.org/10.2807/1560-7917.ES2014.19.15.20770  PMID: 24762663 
  33. Mehand MS, Al-Shorbaji F, Millett P, Murgue B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res. 2018;159:63-7.  https://doi.org/10.1016/j.antiviral.2018.09.009  PMID: 30261226 
  34. Santé publique France (SPF). Liste des maladies à déclaration obligatoire. [List of notifiable diseases]. Saint Maurice: SPF. Updated Aug 2023. Available from: https://www.santepubliquefrance.fr/maladies-a-declaration-obligatoire/liste-des-maladies-a-declaration-obligatoire
  35. Santé publique France (SPF). Centres nationaux de référence pour la lutte contre les maladies transmissibles (CNR). [National reference centres for communicable diseases]. Updated Nov 2024. Available from: https://www.santepubliquefrance.fr/a-propos/nos-principes-fondateurs/centres-nationaux-de-reference-pour-la-lutte-contre-les-maladies-transmissibles-cnr
  36. Agence Nationale de Recherche contre le Sida | Maladies Infectieuses Emergentes (ANRS-MIE). Liste des pathogènes prioritaires ANRS-MIE;2023. [Accessed 12 Nov 2024]. Available from: https://anrs.fr/wp-content/uploads/2023/02/liste-pathogenes-prioritaires-aap-pepr-mie-2023.pdf
  37. World Health Organization (WHO). Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. Geneva: WHO; Jan 2021. Available from: https://www.who.int/publications/i/item/9789240018662
Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Dominique+Ploin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ploin Dominique</a>, <a href="/search?value1=Mathilde+Alexandre&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Alexandre Mathilde</a>, <a href="/search?value1=Bruno+Ventelou&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ventelou Bruno</a>, <a href="/search?value1=Didier+Che&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Che Didier</a>, <a href="/search?value1=Bruno+Coignard&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Coignard Bruno</a>, <a href="/search?value1=Nathalie+Boulanger&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Boulanger Nathalie</a>, <a href="/search?value1=Christophe+Burucoa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Burucoa Christophe</a>, <a href="/search?value1=Fran%C3%A7ois+Caron&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Caron François</a>, <a href="/search?value1=Pierre+Gallian&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gallian Pierre</a>, <a href="/search?value1=Yves+Hansmann&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hansmann Yves</a>, <a href="/search?value1=Christian+Lienhardt&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lienhardt Christian</a>, <a href="/search?value1=Philippe+Minodier&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Minodier Philippe</a>, <a href="/search?value1=Henri+Partouche&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Partouche Henri</a>, <a href="/search?value1=Matthieu+Revest&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Revest Matthieu</a>, <a href="/search?value1=Nadia+Saidani&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Saidani Nadia</a>, <a href="/search?value1=Gilles+Salvat&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Salvat Gilles</a>, <a href="/search?value1=Nicolas+Vignier&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vignier Nicolas</a>, <a href="/search?value1=Sylvie+Floreani&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Floreani Sylvie</a>, <a href="/search?value1=Collaborators%E2%80%99+group&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Collaborators’ group</a>, <a href="/search?value1=Sabine+Henry&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Henry Sabine</a>, <a href="/search?value1=Bruno+Pozzetto&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pozzetto Bruno</a>, <a href="/search?value1=Bruno+Hoen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hoen Bruno</a></span>. Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024. <a href="/content/ecdc">Euro Surveill.</a> 2024;29(50):pii=2400074. <a href="https://doi.org/10.2807/1560-7917.ES.2024.29.50.2400074" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2024.29.50.2400074</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 02 Feb 2024;&nbsp;&nbsp; <span class="generated">Accepted</span>: 21 May 2024 </span> </p>
/content/10.2807/1560-7917.ES.2024.29.50.2400074
/content/10.2807/1560-7917.ES.2024.29.50.2400074
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error